Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer

Journal of Medicinal Food

Volumn 18, Issue 1, 2015, Pages 109-117

  Vieira, Maria Luiza Dos Santos ^a   Fonseca, Fernando Luiz Affonso ^a,b   Costa, Larissa Grossi ^a   Beltrame, Registila Libania ^a   Chaves, Carolina Machado De Sousa ^a   Cartum, Jairo ^a   Do N Alves, Sarah Isabel P M ^b   Azzalis, Ligia Ajaime ^b   Junqueira, Virginia Berlanga Campos ^b   Pereria, Edimar Cristiano ^b   Rocha, Katya Cristina ^a  

^a Departamento de Patologia Faculdade de Medicina Do AB ^*  (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

fatigue; leukemia; liver function; nausea; neoplasia; quality of life; renal function; selenium

Indexed keywords

SELENIUM; ANTINEOPLASTIC AGENT; TRACE ELEMENT;

ADOLESCENT DISEASE; ADVERSE DRUG REACTION; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HODGKIN DISEASE; HUMAN; KIDNEY FUNCTION; LEUKEMIA; LIVER FUNCTION; LIVER TOXICITY; LOSS OF APPETITE; MALE; NAUSEA; NEPHROTOXICITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR; TREATMENT OUTCOME; ADOLESCENT; DAILY LIFE ACTIVITY; DRUG EFFECTS; INFANT; KIDNEY; LIVER; LYMPHOMA; NEOPLASMS; NEWBORN; PRESCHOOL CHILD;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; LEUKEMIA; LIVER; LYMPHOMA; MALE; NAUSEA; NEOPLASMS; QUALITY OF LIFE; SELENIUM; TRACE ELEMENTS;

EID: 84920728122     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.0030     Document Type: Article

References (44)

1. Davis C: Selenium supplementation and cancer prevention. Curr Nutr Rep 2012;1:16-23.
2. Hatfield DL: Selenium: Its Molecular Biology and Role in Human Health, Second edition. Springer, New York, 2006.
3. Cozzolino SMF: Biodisponibilidade de nutrientes, Fourth edition. Manole, Barueri, Saõ Paulo, 2012.
4. Beck MA, Levander OA, Handy J: Selenium deficiency and viral infection. J Nutr 2003;133:1463S-1467S.
5. Cao TM, Hua FY, Xu CM, et al.: Distinct effects of different concentrations of sodium selenite on apoptosis, cell cycle, and gene expression profile in acute promyelocytic leukemia-derived NB4 cells. Ann Hematol 2006;85:434-442.
6. Volp ACP, Bressan J, Hermsdorff HHM, Zulet MA, Martínez JA: Selenium antioxidant effects and its link with inflammation and metabolic syndrome. Rev Nutr 2010;23:581-590.
7. Mattmiller SA, Carlson BA, Sordillo LM: Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis. J Nutr Sci 2013;2:e28.
8. Thornthwaite JT, Shah H, Shah P, Respess H: The natural killer cell: a historical perspective and the use of supplements to enhance NKC activity. J Immune Based Ther Vaccines 2012;1: 21-52.
9. Felix K, Gerstmeier S, Kyriakopoulos A, et al.: Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice. Cancer Res 2004;64:2910-2917.
10. Song H, Hur I, Park H, et al.: Selenium inhibits metastasis of murine melanoma cells through the induction of cell cycle arrest and cell death. Immune Netw 2009;9:236-242.
11. Silva MPN: Anorexia-cachexia syndrome in cancer patients. Rev Bras Cancerol 2006;52:59-77.
12. Mantovani A, Allavena P, Sica A, et al.: Cancer-related inflammation. Nature 2008;454:436-444.
13. Assis FA: Effect of Organic Selenium and vitamin E in the tumor growth and the immune response to the experimental Ehrlich tumor. Masters Thesis; Federal University Minas Gerais; Medicine School; Belo Horizonte, 2007.
14. Walston J, Xue Q, Semba RD, Ferrucci L, et al.: Serum antioxidants, inflammation, and total mortality in older women. Am J Epidemiol 2005;163:18-26.
15. Ferrucci L, Penninx BW, Volpato S, et al.: Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatri Soc 2002;50:1947-1954.
16. Payette H, Roubenoff R, Jacques PF, et al.: Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community- living men and women: the Framingham Heart Study. J Am Geriatr Soc 2003;51:1237-1243.
17. Cappola AR, Xue QL, Ferrucci L, et al.: Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in olderwomen. J Clin Endocrinol Metab 2003;88:2019-2025.
18. Ferrucci L, Harris TB, Guralnik JM et al.: Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999;47:639-646.
19. Zhang J, Johnston G, Stebler B, et al.: Hydrogen peroxide activates NF-jB and the interleukin-6 promoter through NF-jB - inducing kinase. Antioxid Redox Signal 2001;3:3493-3504.
20. Cominetti C, Bortoli MC, Abdalla DSP, Cozzolino SMF: Considerations about oxidative stress, selenium and nutrigenetics. Nutrire 2011;36:131-153.
21. Institute of Medicine, Food and Nutrition Board: Selenium. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. National Academy Press, Washington, DC, 2000, pp. 284-324.
22. Kaasa S, Bjordal K, Aaronson N: The EORTC Core Quality of Life questionnaire (QLQ-C30): validity and reliability when analyzed with patients treated with palliative radiotherapy. Eur J Cancer 1995;31:2260-2263.
23. Fayers PM, Machin D: Quality of Life: Assessment, Analysis and Interpretation of Patient-Reported Outcomes. J. Wiley &Sons Ltd, Hoboken, NJ, 2007.
24. Schwarz R, Hinz A: Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37:1345-1351.
25. Machado SM, Sawada NO: Evaluation quality of life in oncology patients submitted to adjuvant chemotherapy treatment. Texto Contexto Enferm Florianó polis 2008;17:750-757.
26. Kieliszek M, Bazejak S: Selenium: significance and outlook for supplementation. Nutrition 2013;29:713-718.
27. Sieja K, Talerczyk M: Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol 2004;93:320-327.
28. Yoshihara RN, Teixeira BM, Adami F, et al.: Circulating tumor cell detection during chemotherapy in patients with breast cancer is not associated with plasma homocysteine levels. Tumor Biol 2013;34:2937-2941.
29. Yamashita EK, Teixeira BM, Yoshihara RN, et al.: Systemic chemotherapy interferes in homocysteine metabolism in breast cancer patients. J Clin Lab Anal 2014;28:157-162.
30. Hesketh PJ: Chemotherapy-induced nausea and vomiting. New Engl J Med 2008;358:2482-2494.
31. Liberali R, Wanderley FM, Cardoso RM, et al.: Nutritional status of Patients with Neoplasia: systematic review. Essays Sci Biol Sci Agric Health 2011;15:167-182.
32. Ishihara H, Kanda F, Matsushita T et al: White muscle disease in humans: myopathy caused by selenium deficiency in nervous anorexia under long term total parenteral nutrition. J Neurol Neurosurg Psychiatry 1999;67:829-830.
33. Czuczejko J, Zachara BA, Staubach-Topczewska E, et al.: Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases. Acta Biochim Pol 2003;50: 1147-1154.
34. Antunes LMG, Bianchi MDLP: Dietary antioxidants as inhibitors of cisplatin-induced nephrotoxicity. Rev Nutr 2004;17: 89-96.
35. Shilo S, Pardo M, Aharoni-Simon M, et al.: Selenium supplementation increases liver MnSOD expression: Molecular mechanism for hepato-protection. J Inorg Biochem 2008;102:110-118.
36. King PD, Perry MC: Hepatotoxicity of chemotheraphy. Oncologist 2001;6:162-176.
37. Valimaki M, Alfthan G, Pikkarainen J, et al.: Blood and liver selenium concentrations in patients with liver diseases. Clin Chim Acta 1987;166:171-176.
38. Thuluvath PJ, Triger DR: Selenium in chronic liver disease. J Hepatol 1992;14:176-182.
39. Teodor V, Cuciureanu M, Slencu BG, et al.: Potential protective role of selenium in acrylamide intoxication. A biochemical study. Studia Universitatis Vasile Goldis Seria Stiintele Vietii (Life Sciences Series) 2011;21:263-268.
40. Salehi M, Sohrabi Z, Ekramzadeh M, et al.: Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Nephrol Dial Transplant 2013;28:716-723.
41. Baldew GS, Van den Hamer CJ, Los G, et al.: Selenium-induced protection against cis-diammine dichloroplatinum (II) nephrotoxicity in mice and rats. Cancer Res 1989;49:3020-3023.
42. Shenberg C, Izak-Biran T, Mantel M, et al.: Effect of selenite on the toxicity of cis-DDP in mice: estimation of trace elements. J Trace Elem Electrolytes Health Dis 1989;3:71-75.
43. Camargo SMR, Francescato HDC, Lavrador MAS, et al.: Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats. Biol Trace Elem Res 2001;83:251-262.
44. King PD, Perry MC: Hepatotoxicity of chemotherapy. Oncologist 2001;6:162-176.